Overview of Tilidin AL comp.

Quick Facts

Property	Description
Active ingredients	Tilidine Hydrochloride, Naloxone Hydrochloride
Form	Oral tablets (including prolonged-release), Oral solution
Pharmacological class	Opioid analgesic, Combination drug (N02AX)
Common use	Management of moderate to severe pain
Origin	Synthetic

What Type of Medicine is Tilidin AL comp.?

Tilidin AL comp. is classified as a synthetic opioid analgesic that is utilized for the treatment of moderate to severe pain. This preparation is a fixed-dose combination product—the source of the abbreviation "comp."—meaning it contains two distinct active ingredients within a single formulation. The medicine belongs to the high-level pharmacological class of opioids, which are agents acting on specific receptors in the central nervous system. It is administered via the oral route and is available in several oral dosage forms, including tablets (such as prolonged-release forms) and an oral solution. Tilidine/Naloxone serves as a key analgesic option in chronic pain management, providing relief for patients dealing with persistent pain. Tilidin AL comp. is a widely recognized brand in the German market, where this specific combination is often prescribed.

Understanding the Tilidine and Naloxone Composition

The preparation's structure is defined by its two primary active ingredients: Tilidine Hydrochloride and Naloxone Hydrochloride. Tilidine, the core substance providing analgesia, acts as a prodrug which is converted metabolically by the liver into the highly potent compound Nortilidine to achieve its therapeutic effect. Naloxone, conversely, is an opioid antagonist whose role is not pain relief. This unique composition incorporates an abuse-deterrent mechanism; when the medication is taken correctly by mouth, the Naloxone is largely inactivated, allowing the Tilidine component to provide effective pain relief. This dual component structure, specifically the inclusion of the antagonist Naloxone, is a distinguishing feature that differentiates this combination product from simpler, single-ingredient Tilidine formulations.

What side effects are possible with Tilidin AL comp.?

Possible Side Effects and Safety Information

This section outlines the adverse reactions and safety characteristics of the Tilidine/Naloxone combination product, based strictly on official regulatory documentation.

Frequency-Classified Adverse Reactions

The safety profile is defined by effects categorized according to their official frequency. Very Common (ge1/10) reactions include nausea, dizziness, and somnolence (drowsiness). Reactions classified as Common (ge1/100 to <1/10) include vomiting, diarrhea, abdominal pain, headache, anxiety, insomnia, fatigue, and excessive sweating (hyperhidrosis). These adverse reactions are primarily grouped under Nervous System Disorders and Gastrointestinal Disorders.

Serious Adverse Reactions and Safety Constraints

As an opioid analgesic, the medicine's label highlights serious safety concerns, including the risk of Respiratory Depression and the development of Drug Dependence. The inclusion of naloxone, an opioid antagonist, means that improper use can precipitate a Severe Opioid Withdrawal Syndrome. The medicine is Contraindicated in individuals with severe hepatic insufficiency and in cases of acute alcohol intoxication. Caution is also officially noted for patients with renal impairment.

Time-Related Patterns

The incidence of key common adverse reactions, such as dizziness and somnolence, is formally noted to be most frequent at the beginning of treatment and during dose adjustment periods. This highlights an important time-related pattern of exposure that is explicitly stated in the regulatory documentation.

Overdose and Emergency Response

Overdose and when to seek help

Regulatory Focus	Official Documentation
Documented Manifestations	Overdosage is characterized by severe sleepiness, loss of consciousness, and life-threatening respiratory depression (dangerously slow or shallow breathing).
Severe Outcomes	Risk includes ventilatory depression and convulsions. The naloxone component is officially documented as being unable to prevent severe toxicity in cases of massive overdose.
Antidotal Treatment	The official antidote is naloxone, which is used to reverse Central Nervous System (CNS) and respiratory depression; repeated doses may be necessary.

Urgent Medical Care Requirements

Immediate emergency medical attention is strictly required upon any suspicion of overdose, particularly if signs of severe toxicity—such as unresponsiveness or respiratory arrest—are present. Regulators mandate that emergency services be contacted right away. Treatment is classified as symptomatic and supportive, often requiring procedural steps such as gastric lavage in addition to antidote administration. Following initial treatment, the patient must be closely monitored for a minimum of four hours, as the effects of the opioid component may outlast the action of the antidote. This monitoring is critical to manage the risk of recurring toxicity.

Therapeutic Uses of Tilidin AL comp.

The medication is commonly used for the supportive symptomatic management of patients experiencing severe and difficult pain. The therapeutic use of this combination is aligned with management goals for severe pain. The medication is commonly used when symptoms of discomfort are severe enough to require long-term symptomatic support, particularly when supportive relief is needed due to symptom intensity.

The medicine is relevant in conditions characterized by intense, persistent physical discomfort and chronic pain syndromes. It is applied across key clinical scenarios including the management of postoperative recovery after surgery, support for chronic non-malignant pain, and providing assistance in palliative care for tumor-related pain.

The core benefit is that the medication contributes to easing the overall symptom load by addressing the sustained symptomatic challenge.

Quick Fact: Relief for Severe Pain
The medication is applied when symptoms are in the moderate to severe intensity range and is used for intense somatic and persistent pain when additional symptomatic support is needed.

Eligibility and Restrictions for Use

The official regulatory documents define clear constraints on who can and cannot use Tilidin AL comp., primarily through absolute contraindications and population-specific restrictions. The medicine is indicated for use in adults and adolescents aged 14 years and older.

Eligibility Classification	Population Rule (Regulatory Basis)
Absolute Contraindication	Patients with established opioid dependence must not use the medicine; this is due to the Naloxone component which can precipitate acute withdrawal. Use is prohibited with Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of their cessation, and in cases of acute intoxication (alcohol, hypnotics, etc.).
Major Restrictions	The medicine is generally contraindicated in severe hepatic impairment and not recommended for patients with severe renal impairment (e.g., creatinine clearance < 10 ml/min).
Age-Related Exclusion	Use is not recommended or contraindicated for children under 14 years of age due to insufficient clinical data.
Physiological Status	Use is generally not recommended during pregnancy and is contraindicated during lactation (breastfeeding), as the active substance passes into breast milk.

The regulatory profile establishes these limitations by classifying groups where the risk of use or lack of safety data is unacceptable, alongside special cautions for patients with conditions like increased intracranial pressure or disturbances of consciousness.

What should I know about interactions with other medicines?

Tilidin AL comp. contains tilidine (an opioid analgesic) and naloxone (an opioid antagonist) and can interact with various other medications, resulting in increased risks or altered effectiveness. Always inform your doctor or pharmacist about all prescription, over-the-counter, and herbal supplements you are taking.

Medications to Use with Caution

Central Nervous System (CNS) Depressants: Concurrent use with medicines that depress the CNS—including but not limited to alcohol, sedatives (e.g., benzodiazepines), sleeping pills, other opioids, and certain antidepressants—can lead to additive effects. This significantly increases the risk of severe sedation, respiratory depression (slowed or shallow breathing), coma, and potentially death. This combination should be avoided or used with careful dose adjustment and close medical supervision.
Serotonergic Drugs: Co-administration with drugs that increase serotonin activity, such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and Monoamine Oxidase Inhibitors (MAOIs), may increase the risk of serotonin syndrome. This is a potentially life-threatening condition characterized by mental status changes, hyperthermia, and neuromuscular abnormalities. MAOIs should be stopped at least 14 days before starting Tilidin AL comp.
Cytochrome P450 Enzyme Inhibitors/Inducers: Tilidine is metabolized in the liver by enzymes, primarily CYP3A4 and CYP2C19. Drugs that inhibit these enzymes (e.g., some antifungals or certain macrolide antibiotics) can increase the concentration of active tilidine metabolite, potentially enhancing its effects and side effects, including respiratory depression. Conversely, enzyme inducers can decrease the active metabolite's concentration, leading to reduced analgesic efficacy. Consult your healthcare provider about necessary dose adjustments.

Mechanism of Action

Tilidin AL comp. functions via its two components. The primary substance, Tilidin, is a prodrug that is quickly metabolized in the liver to its biologically active form, nortilidin. Nortilidin acts as an agonist at the mu-opioid receptor, which is a G-protein coupled receptor (GPCR) predominantly located in the central nervous system. The mu-opioid receptor agonism initiates an intracellular cascade that ultimately hyperpolarizes neurons, leading to the inhibition of ascending nociceptive transmission along the pain pathways. The second component, Naloxone, is a competitive antagonist at the same mu-opioid receptor. The combination design leverages Naloxone's receptor antagonism to modulate the overall systemic mu-opioid effect when the product is administered.

Dosage and Administration Information

Instruction Map: How to use Tilidin AL comp.

Feature	Guideline/Rule
Route of administration	Oral (by mouth). This route is critical for the drug's fixed combination structure.
Dosing schedule	Dosage is determined by individual titration, often beginning with the oral solution. Sustained-release tablets are available in multiple strengths, including 50 mg, 100 mg, and 200 mg Tilidine equivalent.
Timing in relation to meals (if applicable)	Prescribing information generally indicates that intake is independent of meals.
Preparation requirements (if applicable)	The sustained-release tablets must be swallowed whole to preserve the prolonged-release properties and the integrity of the abuse-deterrent system.
Age-group administration rules	Hepatic Impairment: Administration is questioned in cases of severe hepatic impairment, as the liver's function is required to convert Tilidine into its active compound and to sufficiently inactivate Naloxone.
Missed-dose rules	Specific guidance on handling a missed dose may vary; patients are generally advised to resume the prescribed schedule.
Special procedural conditions	The medicine must be gradually tapered upon discontinuation to manage potential opioid withdrawal.

Instruction classifications (high-level)

Classification	Description
Administration method type	Oral (using both liquid solution and solid tablets).
Frequency pattern	Divided use (typically twice daily for sustained-release tablets).
Basis of use	Based on established product information.
Use-context constraints	Dosage adjustments are based on individual analgesic response and metabolic function.

Resulting procedural structure

Step sequence:

Therapy is initiated orally to allow for dose titration.
The established dose is maintained, often via the sustained-release tablets administered on a fixed twice-daily schedule.
Sustained-release tablets are ingested whole to ensure proper release kinetics.
Discontinuation of therapy must involve a procedure of gradual dose reduction.

Connection to the overall use protocol:

The use protocol is structured around the requirement for individual dose titration using flexible forms, followed by maintenance using a fixed, twice-daily schedule with sustained-release tablets. The mandated oral administration is a central instruction that ensures the combination product functions as intended, while adjustments for hepatic impairment are critical constraints for proper use.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Summary of Clinical Trials

Research has studied Drug X in relation to symptoms of Condition A. One study compared Drug X to a leading over-the-counter competitor. Studies investigated outcomes related to the duration and severity of flare-ups following administration of Drug X.

Clinical trials examined the safety profile in adult patients, but individuals with pre-existing heart conditions were generally excluded from studies or had specific safety monitoring.

Investigated Mechanism and Symptom Evaluation

Studies evaluated the timeframe for changes in symptom severity following administration of the combination of ingredients in Drug X and exploratory findings related to its action. Clinical evidence has explored whether Drug X was administered during assessments of sustained change in chronic symptoms.

Administration Timing and Quality of Life

Research examined study participant data related to administration timing in relation to symptom manifestation.

One study assessed whether the use of Drug X was associated with changes in patient quality of life after one week. The research did not definitively establish a causal link for this outcome. Exploration of long-term effects remains an area of active research.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Tilidin AL comp. (FAQ)

Q: Is Tilidin AL comp. the same as other opioid-like pain medicines?

According to official product information, this is a synthetic opioid analgesic. It is noted as being different from simpler, single-ingredient opioids because it contains a second component, Naloxone. This unique combination is designed as an abuse-deterrent feature.

Q: How quickly does Tilidin AL comp. usually start to work?

Pharmacokinetic studies indicate that the medicine's primary active substance, nortilidine, is typically absorbed and reaches its highest level in the blood within one to two hours after taking the tablet. This timeframe describes when the substance is most concentrated for its intended effect.

Q: How long does the effect of Tilidin AL comp. last?

For the sustained-release tablet formulation, the official dosing schedule is typically twice daily. This frequency is based on the design of the medicine to provide effective levels of the active substance over a 12-hour period.

Q: Can I take Tilidin AL comp. with commonly available pain relievers?

Official regulatory documents caution against concurrent use with any medicine that has effects on the central nervous system, including other opioids. The potential for additive effects is noted in official documents. Specific non-opioid pain relievers are typically not individually listed in official warnings.

Q: Are there any common foods or drinks that should be avoided when taking Tilidin AL comp.?

Alcohol is strictly listed in official regulatory documents as a substance that should be avoided when taking this medicine. Its use is contraindicated because it significantly increases the risk of severe central nervous system effects. The official product information describes the medicine's absorption as independent of non-alcoholic food.

Q: Why do doctors prescribe Tilidin AL comp. instead of a single-ingredient painkiller?

The preparation is designed to include Naloxone, which is the main difference from single-ingredient Tilidine formulations. This component is included as part of an abuse-deterrent system.

Q: Are there studies that support the use of Tilidin AL comp. for long-term pain?

The medicine is officially indicated for the management of moderate to severe pain, which confirms its regulatory approval for use in the context of chronic pain management. Clinical analysis has examined the combination and notes its role in the management of persistent pain.

Q: What are the signs that a side effect from Tilidin AL comp. might be serious?

Regulatory documents highlight the risk of respiratory depression as a serious adverse reaction. This condition involves slowed or shallow breathing. This safety concern is officially noted as being most frequent at the start of treatment, when close monitoring by a healthcare provider may be appropriate.

Q: What should I tell my healthcare provider about before starting Tilidin AL comp.?

Official prescribing information establishes specific contraindications. Contraindicated conditions include severe liver impairment, established opioid dependence, or concurrent use with MAO Inhibitors.

Q: Can Tilidin AL comp. cause issues with constipation?

Constipation is a known gastrointestinal side effect associated with the use of opioid-class medicines. While other digestive issues are also listed, official documents reflect that constipation is a possible effect.

Q: What is the official classification of this drug regarding its potential for misuse?

Due to its active opioid component and the potential for dependence, the medicine is classified by national regulatory authorities as a controlled substance. This classification reflects the need for specific oversight regarding its dispensing and use.

Q: Can Tilidin AL comp. be used for acute injury pain?

The medicine is officially indicated for the treatment of moderate to severe pain. While often associated with chronic pain management, this broad indication technically covers acute pain. The medicine is available in several dosage forms, including an oral solution.

Q: Does the presence of Naloxone eliminate all risks associated with Tilidin?

The official warnings indicate that Naloxone's role is primarily related to misuse deterrence. However, its presence does not eliminate the risk of drug dependence or other serious adverse reactions, such as respiratory depression, when the medicine is taken correctly as prescribed.

Q: Can older adults use Tilidin AL comp.?

Regulatory documents describe that use in elderly patients may require specific caution and monitoring. This attention is often noted in relation to the initial amount of medicine given.

Q: Is the maximum daily amount of Tilidin AL comp. fixed for everyone?

Yes. Although the starting amount of medicine is adjusted to the individual, official regulatory documents define a definitive maximum daily dose. This upper limit should not be exceeded under any circumstances.

Q: Can Tilidin AL comp. affect my ability to drive or operate machinery?

Official safety sections clearly state that the medicine can impair the ability to perform skilled tasks. This is due to common side effects like dizziness and drowsiness.

Q: Can the effectiveness of Tilidin AL comp. change over time?

Official warnings note that like other medicines in the opioid class, a patient's body may become less responsive to the pain relief over time. This common phenomenon is officially described as developing tolerance.

Q: Are there known effects of Tilidin AL comp. on blood pressure?

Regulatory documents list effects on the circulatory system among possible side effects. In some instances, the medicine is known to cause hypotension, or low blood pressure.

Q: What should I do if I think I'm experiencing an allergic reaction to Tilidin AL comp.?

Official safety instructions advise that if a hypersensitivity reaction (allergic reaction) is suspected, the use of the medicine should be discontinued immediately. Official safety instructions note that expert medical help should be sought promptly for signs of a hypersensitivity reaction.

Q: Is Tilidin AL comp. available over the counter anywhere?

Official regulatory status across various countries confirms that this medicine is classified as a prescription-only drug. It is not available for purchase without a prescription.

How should Tilidin AL comp. be stored and disposed of?

How to Store and Dispose of Tilidin AL comp.?

Tilidin AL comp. must be stored under specific regulatory conditions to maintain stability and effectiveness.

Official Storage Requirements

The medicine must be strictly kept out of the sight and reach of children.

Storage temperature must not be above +30 °C.

For stability, the medication must be stored in the original packaging to protect the contents from moisture. Prolonged-release tablets should only be removed from the blister pack immediately before use. The product must not be used past the expiration date printed on the packaging.

Disposal Instructions

Unused or expired medicine must be disposed of according to national requirements. It is officially prohibited to dispose of Tilidin AL comp. via wastewater (e.g., sink or toilet).

Tilidin AL comp.